new york dcat annual dinner

1
Above, C P. Frailey, executive vice president, American Drug Manufacturers Association; C Gray Frailey, DCAT Washington representative; Maj. Gen. L. R. Groves; V. E. Williams, Monsanto Chemical Co.; J. P. Remen- snyder, Heyden Chemical Co. Above. II. C. Green, L. Sonneborn Sons, Inc.; K, L. Patterson, president, Ν. Υ. Oil Trades Associa- tion; R. B. Magnus, treas- urer, DCAT Section; J. Mclnnes, Jr., president, SAACI. Left. J. J. Toohy, DCAT council; P. B. Hofmann and Frank M. Head, DCAT ex- ecutive committee; E. H. Killheffer, Du Pont JL HE Drug, Chemical and Allied Trades Section of the New York Board of Trade held its 20th annual dinner at the Hotel Waldorf-Astoria in New York on March 14. Over 5,000 representatives of the chemical and pharmaceutical industries were seated in the multi-tiered Grand Ballroom of the hotel to hear Maj. Gen. Leslie R. Groves, head of the Man- hattan Project, principal speaker. The gathering was greeted by the chair- man of the section, Harold M. Altschul. Mr. Altschul spoke of the ô6-year history of the DCAT and emphasized the fact that it represents a full cross section of the entire industry to whom it renders all the services of a trade association and in addi- tion those of public representation. This latter function was especially important, he believed, whenever a segment of the industry found itself confronted with ex- treme legislation or regulation. Limited trade groups are unable to defend them- selves against the accusation of self-in- terest, he continued, but an association encompassing representatives of many fields can express an authoritative broad- gage viewpoint which will bear weight on behalf of the group under attack. General Groves, in his address, remarked on the different attitude on scientific ap- proach to a problem that had to be taken in the development of the atomic bonab. There was no time for the pilot plant or mock-up on this project and the transi- tion from laboratory stage to production scale was made on the most part without the benefit of intermediate study. General Groves also stated that pending the adoption of legislation by the Congress to set up a permanent government body to handle atomic energy, the War Depart- ment is continuing research and develop- ment work in this field, not only on mili- tary applications but on broader aspects as well. To assist him in evaluating tfce different proposals of possible research, General Groves announced that he had requested the counsel of several eminent scientists including R. F. Bâcher of Cor- nell University, A. H. Compton, Chancel- lor of Washington University, W. K. R, E. Borland, Dote Chemical Co,, F, J, Cullen 9 executive vice president, and president, TV. Y. Board of Proprietary Association of America; Trade j Maj. Gent~A, H, Waitt, J, E, Hopkins, J, L. Hopkins & Co.; Chief, CWS; C, M, Anderson, W, R. M. Wharton, chief, Eastern THs- Merch & Co, and DCAT council trict, Food and Drug Administration Lewis of Massachusetts Institute of Technology, Lt. Col. John R. Ruhoff, C. A. Thomas of Monsanto Chemical Co., R. C. Tolman, dean of graduate school, California Institute of Technology, and John A. Wheeler, Princeton University. The safe declassification of technical information on atomic energy research without endangering national security has been accomplished according to recommendations of a committee of scientists headed by R. C. Tolman. This committee, Groves revealed, has approved the publication of the Smyth report: "In- deed there was very little scientific in- formation given in the Smyth report be- yond that which had already been re- ported in the scientific literature.' , General Groves concluded his remarks by saying that he believed this policy of declassification of technical information within the limits set up by the Tolman committee will make possible the utiliza- tion of this material gained during the war for peacetime uses without endanger- ing the security of the United States. C, C. Concannon, Chemicals and Drugs, Department of Commerce; H, L. Brooks, chairman, executive com· mittee, TV. Y, Board of Trade; G. L. Marsters, DCAT advisory council VOLUME 2 4. NO. 7 APRIL 10, 1946 919 New York DCAT Annual Dinner

Upload: phamdien

Post on 22-Feb-2017

214 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: New York DCAT Annual Dinner

Above, C P. Frailey, executive vice president, American Drug Manufacturers Association; C Gray Frailey, DCAT Washington representative; Maj. Gen. L. R. Groves; V. E. Williams, Monsanto Chemical Co.; J. P. Remen-snyder, Heyden Chemical Co.

Above. II. C. Green, L. Sonneborn Sons, Inc.; K, L. Patterson, president, Ν. Υ. Oil Trades Associa­tion; R. B. Magnus, treas­urer, DCAT Section; J. Mclnnes, Jr., president, SAACI. Left. J. J. Toohy, DCAT council; P. B. Hofmann and Frank M. Head, DCAT ex­ecutive committee; E. H. Killheffer, Du Pont

JL HE Drug, Chemical and Allied Trades Section of the New York Board of Trade held its 20th annual dinner at the Hotel Waldorf-Astoria in New York on March 14. Over 5,000 representatives of the chemical and pharmaceutical industries were seated in the multi-tiered Grand Ballroom of the hotel to hear Maj. Gen. Leslie R. Groves, head of the Man­hattan Project, principal speaker.

The gathering was greeted by the chair­man of the section, Harold M. Altschul. Mr. Altschul spoke of the ô6-year history of the DCAT and emphasized the fact that it represents a full cross section of the entire industry to whom it renders all the services of a trade association and in addi­tion those of public representation. This latter function was especially important, he believed, whenever a segment of the industry found itself confronted with ex­treme legislation or regulation. Limited trade groups are unable to defend them­selves against the accusation of self-in­terest, he continued, but an association encompassing representatives of many

fields can express an authoritative broad-gage viewpoint which will bear weight on behalf of the group under attack.

General Groves, in his address, remarked on the different attitude on scientific a p ­proach to a problem that had to be taken in the development of the atomic bonab. There was no time for the pilot plant or mock-up on this project and the transi­tion from laboratory stage t o production scale was made on the most part without the benefit of intermediate study.

General Groves also stated that pending the adoption of legislation by the Congress to set up a permanent government body to handle atomic energy, the War Depart­ment is continuing research and develop­ment work in this field, not only on mil i ­tary applications but on broader aspects as well. To assist him in evaluating tfce different proposals of possible research, General Groves announced that he h a d requested the counsel of several eminent scientists including R. F. Bâcher of Cor­nell University, A. H. Compton, Chancel­lor of Washington University, W. K .

R, E. Borland, Dote Chemical Co,, F, J, Cullen9 executive vice president, and president, TV. Y. Board of Proprietary Association of America; Trade j Maj. Gent~A, H, Waitt, J, E, Hopkins, J, L. Hopkins & Co.; Chief, CWS; C, M, Anderson, W, R. M. Wharton, chief, Eastern THs-Merch & Co, and DCAT council trict, Food and Drug Administration

Lewis of Massachusetts Institute of Technology, Lt. Col. John R. Ruhoff, C. A. Thomas of Monsanto Chemical Co., R. C. Tolman, dean of graduate school, California Institute of Technology, and John A. Wheeler, Princeton University.

The safe declassification of technical information on atomic energy research without endangering national security has been accomplished according to recommendations of a committee of scientists headed by R. C. Tolman. This committee, Groves revealed, has approved the publication of the Smyth report: "In­deed there was very little scientific in­formation given in the Smyth report be­yond that which had already been re­ported in the scientific literature.' ,

General Groves concluded his remarks by saying that he believed this policy of declassification of technical information within the limits set up by the Tolman committee will make possible the utiliza­tion of this material gained during the war for peacetime uses without endanger­ing the security of the United States.

C, C. Concannon, Chemicals and Drugs, Department of Commerce; H, L. Brooks, chairman, executive com· mittee, TV. Y, Board of Trade; G. L. Marsters, DCAT advisory council

V O L U M E 2 4. N O . 7 A P R I L 1 0 , 1 9 4 6 919

New York DCAT Annual Dinner